The Hidden Costs of Ozempic and Mounjaro: A Pathologist’s Perspective
GLP-1 receptor agonists, including Ozempic and Mounjaro, show significant weight-loss efficacy but carry risks like gastrointestinal distress and potential long-term safety concerns, according to recent clinical reviews and regulatory analyses. ... Read More